WHO methodology for the selection of priority medical devices for NCD management Medical technologies for essential cardiovascular, stroke, diabetes, and.

Slides:



Advertisements
Similar presentations
Measuring and Monitoring UHC: Global framework and its application in Bangladesh Tanvir Huda International Centre for Diarrhoeal Disease Research, Bangladesh.
Advertisements

Midland Region Primary Healthcare Forum 30 May 2014.
Non Communicable Disease
Course 17: Neglected Tropical Diseases & NCDs 9 th GA of IAPB Hyderabad; 19 th September 2012 NCDs & Eye Health Converging interests and opportunities.
WHO-FIC Network Annual Meeting 2014 | October 2014, Barcelona, Spain 1 |1 | WHO-FIC Council Update from WHO Regional Office for the Western Pacific.
Non-communicable diseases David Redfern
CSL 409. WHO  The World Health Organization (WHO) is a specialized agency of the United Nations (UN) that acts as a coordinating authority on international.
Availability Accessibility Acceptability Quality Satisfaction Continuity of care Impacts Reach and outcomes Health Sector Non-Health Sector Outputs Education.
Dr. Joseph Mbatia Assistant Director and Head, NCD, Mental Health and Substance Abuse Ministry of Health and Social Welfare (Tz. Mainland)
Lucile de Comarmond Chief Pharmacist Workshop on Impact of TRIPS/IP on Access to Medicine September 2014.
Global Alliance against Chronic Respiratory Diseases GARD/NCD Action Plan & 2011 UN Summit on NCDs Niels H. Chavannes MD PhD Associate.
LEVELS OF HEALTH CARE VINITA VANDANA.
Cardiovascular Disease Healthy Kansans 2010 Steering Committee Meeting April 22, 2005.
TANZANIA MAINLAND NATIONAL HEALTH POLICY AND STRATEGY REPORT.
Supporting measurement & improvement of primary health care (PHC) at the facility and community levels Dr. Jennifer Adams, Deputy Assistant Administrator,
Outline of Current Situation Survey on HIV/AIDS (Proposal) Ms. Keiko Dozono Director for AIDS and Emerging Infectious Disease Control Health and Safety.
Rural West Primary Health Care (PHC) Team December 9 – 10, Calgary.
INJURY EPIDEMIOLOGY Dr.Ibrahim Gosadi, Dr.Salwa Tayel KSU Dept of Family & Community Medicine.
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Nick Banatvala & Pascal Bovet
Non-communicable diseases (NCDs) include:
Improving Program Budgeting in Ukraine’s Fiscal Process
Chronic Non-Communicable Diseases
Quality Improvement An Introduction
NCD policy and programming in Croatia
WHO strategy on HIV/AIDS “Getting to Zero”
WHO Surveillance Tools for NCD Risk Factors – Instruments and Data Sources Surveillance and Population-based Prevention Unit Department for Prevention.
UGANDA: Budgeting, resource tracking and domestic advocacy practices.
*Philippa Boulle1, Gustavo Fernandez1, Maria Lightowler2
NCD in Bulgaria Assoc. Prof. Plamen Dimitrov, MD, PhD
World Health Organization
BUILDING INTEGRATED HEALTH SERVICE DELIVERY NETWORKS
Measuring Progress Toward UHC
WHO’s prioritised research agenda for the prevention and control of NCDs prioritises
NON-COMMUNICABLE DISEASES IN BHUTAN
Impact and costing of cardiovascular disease treatmentin Kwara State Health Insurance (KSHI) program. University of Ilorin Teaching Hospital (UITH) Amsterdam.
Health Reform, HITECH and Workforce
Prevention and Control of Noncommunicable Diseases
How does teamwork improve value. Dr Nils E
prevention and control of non communicable diseases in Iraq
Non Communicable Diseases State of Qatar
Medical devices, new developments and concerns
Julita Maradzika Zororo Gandah Brian A. Maponga
GARD/NCD Action Plan & 2011 UN Summit on NCDs
World Health Organization
Non-communicable diseases (NCDs) include:
HSA 535 RANK Education for Service-- hsa535rank.com.
National health policy review
Effective and humane care for all with mental, neurological,
NCD – Kingdom of Saudi Arabia
Integrating HTA into Public Health Policies
Importance OF CAUSE OF DEATH DATA
Essential Drugs and Medicines Policy
Chairperson, Alzheimer’s and Related Disorders Society of India
National Cancer Center
Community Health Needs Assessment
The Arizona Chronic Disease Plan:
Essential Drugs and Medicines Policy
Supporting Implementation of the EDL
Dr Manisha Shridhar Regional Advisor WHO-SEARO
Towards International Harmonized Nomenclature for Medical Devices
Medical devices for NCDs
Health conditions DCP3 Recommendations ICD11 Categorization Cardiac Dx
Medical Devices : Challenges for Non-Communicable Diseases
WHO Department of Essential Medicines and Health Products
National Health Policy and Strategic Shifts
Dr Timothy Armstrong Coordinator
Ingredients of a Sustainable healthcare SYSTEM– the Cayman islands experience Lizzette Yearwood.
Chantal INGABIRE 29 March 2019 EAHRC Conference/ Tanzania
World Health Organization
Presentation transcript:

WHO methodology for the selection of priority medical devices for NCD management Medical technologies for essential cardiovascular, stroke, diabetes, and chronic respiratory disease health-care interventions Title : Diabetes in India Credit : WHO /Atul Loke Date of exposure : 12/02/2016 13/12/18 M de Mar Elena, Karen Kulp and Adriana Velazquez Berumen

These interventions often rely on access to medical devices. Introduction: Sustainable Development Goals - Goal 3: Ensure healthy lives and promote well-being for all ages 71% of global deaths caused by noncommunicable disease 40% die before their 70th birthday 85% of early deaths from noncommunicable disease occur in low- and middle-income countries Morbidity and mortality can be reduced through early detection and effective management. These interventions often rely on access to medical devices. https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death; https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

How do you select, procure and use so many different products? Challenges: Providing health-care to manage non-communicable disease requires resources. So, which investments are the most beneficial?   NCD target to be attained by 2025: “An 80% availability of the affordable basic technologies and essential medicines, incl. generics, required to treat NCDs” There are over 10,000 different types of medical devices and over 500,000 products commercially available. How do you select, procure and use so many different products? https://www.who.int/news-room/fact-sheets/detail/the-top-10-causes-of-death; https://www.who.int/news-room/fact-sheets/detail/noncommunicable-diseases

Tertiary care Secondary care Primary care    The clinical interventions need technologies that should be appropriate for each health care facility, to respond to health care worker and population needs within the financial constraints   Tertiary care Secondary care Primary care Tertiary Specialized care Regional or teaching hospital Specialized outpatient diagnostics or treatment Secondary District and regional hospitals Outpatient labs and clinics Primary Community health centers Health post or health center Self use Home

Priority intervention medical device packages by income level Fragile states: 1.Basic intervention packages Low health care coverage: 1.Vulnerable populations 2.Vaccinations 3.Diagnostic Medium health care coverage: 1.Prevention, health promotion, and diagnostics 2.Limited treatments 3.Rehabilitation 4.Specialized NCD interventions 5.Vertical programs for specific or vulnerable populations (as resources allow) Strong health system with universal coverage: 1.Prevenataive services 2.Diagnostics 3.Treatments 4.Rehabilitation 5.Palliative care 6.Home care/telehealth 7.Age-specific interventions Health Systems for UHC The need to prioritize is higher where resources are limited Population coverage, financial, technological resources and health workforce

Previous publications in this series: Objective: To develop a list of priority medical devices for selected noncommunicable diseases Previous publications in this series:

International Classification of Diseases: codification of WHY the use of a medical device is needed ICD-11 is the 11th revision of the International Classification of Diseases. Epidemiology, health management, and clinical use. Analysis of the general health of population groups. Monitoring the incidence and prevalence of diseases. Providing a picture of the general health situation of countries. ICD-11 is used for: ICD-11 LINK: https://icd.who.int/

International Classification of Health Interventions: codification of HOW the medical device was used International Classification of Health Interventions began in 2007. ICHI Beta-2 2018 is now available. Recording information about clinical interventions. Enabling statistical analysis and international comparison. Monitoring interventions across healthcare delivery settings. Codifies the target, action and means of an intervention. ICHI is used for: ICHI LINK: https://mitel.dimi.uniud.it/ichi/

A pilot of the new ICMD system is being presented at this forum! International Classification of Medical Devices: codification of WHAT medical device was used A pilot of the new ICMD system is being presented at this forum! Registration for market approval for patient/clinician safety Tracking for post-market surveillance for patient/clinician safety Supporting efficient exchange of information for UHC Simplify procurement, supply chain, inventory and budgeting Standardization of processes throughout the lifecycle of the device ICMD will be used for: ICMD LINK: https://icd.who.int/dev11/l-m/en X Extension Codes / Health Devices, Equipment and Supplies

Cardiovascular disease: Current status of the project We are here

Example of the cross-referenced list for cardiovascular disease 23/05/2019

Example of the cross-referenced list for cardiovascular disease

Stroke: Current status of the project We are here

Example of the cross-referenced list for stroke

Diabetes: Current status of the project We are here

Example of the cross-referenced list for diabetes

Chronic respiratory diseases: Current status of the project We are here

WHO kindly requests your assistance Please help us make this list of priority medical devices for selected noncommunicable diseases ready and available. Review Consult Collaborate and disseminate To review the list of health interventions derived from clinical guidelines and the list of associated medical devices. To consider the possibility of participation in consultations to be held in the coming months where these lists will be reviewed and finalized with the input of other global experts from each of the six WHO regions. To consider ongoing collaboration on mattered related to this project, including providing your input into the content of the upcoming publication for dissemination as a freely available public good.

Thank you! Adriana Velazquez Berumen, M de Mar Elena and Karen Kulp WHO 20, Avenue Appia 1211 Geneva